ENDOMETRIOID ADENOCARCINOMA
Clinical trials for ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New collagen shot may help young women beat uterine cancer without hysterectomy
Disease control Recruiting nowThis study tests whether injecting a lab-made collagen into the uterus, along with daily hormone pills, can help shrink early-stage endometrial cancer or precancerous growths. The goal is to preserve fertility in women aged 45 or younger. Thirty participants will either receive t…
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Wang Jianliu • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
Immunotherapy duo shows promise against tough uterine cancer
Disease control Recruiting nowThis study is for people with recurrent endometrial cancer that has a specific DNA repair problem (called dMMR). It compares a combination of two immunotherapy drugs (nivolumab and ipilimumab) against nivolumab alone to see which shrinks tumors better. About 81 participants will …
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Large study aims to pinpoint cancer return rates and swelling risks after treatment
Knowledge-focused Recruiting nowThis study is observing about 1,715 people with early-stage endometrial cancer to see how often the cancer comes back and how often lymphedema (swelling) happens after standard treatment. Participants will have regular check-ups for 36 months. The goal is to gather real-world dat…
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 18:01 UTC